SUMIT PHARMACY · EDITORIAL

Pharmacy Knowledge. Industry Insights. Career Growth.

Explore pharmaceutical industry updates, regulatory developments, career opportunities, pharmacy education and practical insights for pharmacy students and professionals.

Pharmacy News & Updates Career & Education Regulatory Insights

EXPLORE TOPICS

All Types Career Guidance PCI Updates Pharma Jobs Pharma News Regulatory Affairs

CATEGORY ARCHIVE

Pharma News

Stay informed with the latest developments, useful guides and educational resources.

New articles and updates

IPC drug safety alerts 2026 for levetiracetam, xylometazoline and oxymetazoline

IPC Drug Safety Alerts 2026: Levetiracetam, Xylometazoline and Oxymetazoline – Side Effects, Risks and Pharmacist Guidance

The Indian Pharmacopoeia Commission (IPC) has flagged three commonly used medicines for suspected adverse drug reactions (ADRs): levetiracetam, xylometazoline and oxymetazoline. The reported safety concerns include gingival hypertrophy (abnormal enlargement of gum tissue) associated…

By Sumit Singh · Nov 6, 2026

Read article

Explore the latest updates

Anti cancer drug price update 2026 – NPPA revised MRP of 543 brands

Pharma News

Anti-Cancer Drug Price Update 2026: NPPA Revises MRP of 543 Brands, New Prices from 9 November

India is preparing for a major change in anti-cancer drug pricing. Under the anti cancer drug price update 2026, the National…

Sumit Singh · Nov 5, 2026

Read article

Drug licence suspension proposal 2026 in India for substandard medicines and pharmaceutical quality failures

Pharma News

India Proposes Immediate Drug Licence Suspension 2026: New Rules for Substandard Medicines Explained

Drug licence suspension proposal 2026 is an important regulatory development for India’s pharmaceutical industry. The Ministry of Health and Family Welfare…

Sumit Singh · Nov 4, 2026

Read article

Pharma News

CDSCO High-Risk Solvents 2026: Digital Tracking System, ONDLS and New NOC Requirements Explained

Last Updated: 3 November 2026 The CDSCO high-risk solvents 2026 regulatory update is an important development for India’s pharmaceutical manufacturing and…

Sumit Singh · Nov 3, 2026

Read article

Generic oral semaglutide tablets and GLP-1 receptor drug research in India

Pharma News

Generic Oral Semaglutide in India 2026: Sun Pharma Gets CDSCO Approval – Mechanism, Patent Dispute and Launch Status

Last Updated: 3 November 2026 Generic oral semaglutide in India is becoming an important development in the pharmaceutical industry. On 31…

Sumit Singh · Nov 3, 2026

Read article

Schedule H1 Drugs List 2026 showing current drugs, prescription rules and latest regulatory changes in India

Pharma News

Schedule H1 Drugs List 2026: Updated List, Rules, Prescription Requirements & Latest Changes

Last updated: 3 October 2026 If you are searching for the Schedule H1 drugs list 2026, there is an important point…

Sumit Singh · Oct 3, 2026

Read article

Featured illustration explaining the AI-generated prescriptions ban debate in India, covering e-pharmacy regulation, fake prescriptions, AIOCD protest, and CDSCO regulatory review.

Pharma News

AI-Generated Prescriptions Ban Debate in India (2026): The Complete Explainer

AI-generated prescriptions ban debate in India has become one of the biggest regulatory controversies in the Indian pharmaceutical sector in 2026.…

Sumit Singh · Jul 4, 2026

Read article

Pharma News

Cough Syrup Prescription Rule India 2026: New Schedule K Rule Explained

The cough syrup prescription rule India 2026 marks one of the biggest regulatory changes in Indian pharmacy practice. Under the Drugs…

Sumit Singh · Jul 4, 2026

Read article

Pharmacy Knowledge. Industry Insights. Career Growth.

Pharma News

IPC Drug Safety Alerts 2026: Levetiracetam, Xylometazoline and Oxymetazoline – Side Effects, Risks and Pharmacist Guidance

More Articles

Anti-Cancer Drug Price Update 2026: NPPA Revises MRP of 543 Brands, New Prices from 9 November

India Proposes Immediate Drug Licence Suspension 2026: New Rules for Substandard Medicines Explained

CDSCO High-Risk Solvents 2026: Digital Tracking System, ONDLS and New NOC Requirements Explained

Generic Oral Semaglutide in India 2026: Sun Pharma Gets CDSCO Approval – Mechanism, Patent Dispute and Launch Status

Schedule H1 Drugs List 2026: Updated List, Rules, Prescription Requirements & Latest Changes

AI-Generated Prescriptions Ban Debate in India (2026): The Complete Explainer

Cough Syrup Prescription Rule India 2026: New Schedule K Rule Explained

Need help with notes or downloads?